Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01678482 |
Recruitment Status :
Completed
First Posted : September 5, 2012
Last Update Posted : September 5, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual.
The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Monitor Acne Lessions Count Reduction as Result of Usinfg the Device | Device: light based device for treatment of acne | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 50 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne. |
Study Start Date : | November 2011 |
Actual Primary Completion Date : | April 2012 |
Actual Study Completion Date : | April 2012 |
Arm | Intervention/treatment |
---|---|
Experimental: lession count reduction post treatment
|
Device: light based device for treatment of acne |
- Acne lession count [ Time Frame: 3 months post treatment ]acne count post treatment compared to based line count

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Presence of mild to moderate acne.
- Skin Type I to VI (Fitzpatrick).
- Males or females who are 21-65 years old.
- Willingness to follow the treatment schedule, post-treatment care and have photographs taken.
Exclusion Criteria:
- Pacemaker or internal defibrillator.
- Permanent implant in the treated area, such as metal plates and screws or silicon, unless deep enough in the bone.
- Skin areas that have been injected with Botox/ Hyaluronic acid /collagen/fat injections or other augmentation methods with bio-material during last 6 months.
- Current or history of skin cancer, or any other type of cancer, or pre-malignant moles.
- Current severe medical conditions, such as heart and lung disorders.
- Pregnant or breastfeeding.
- Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
- History of diseases stimulated by heat, such as recurrent Herpes Simplex (cold sores) in the treatment area, unless treated by following a preventive regime.
- Poorly controlled endocrine disorders, such as diabetes or thyroid disorders.
- Any active skin condition in the treatment area, such as sores, psoriasis, eczema, and rash and rosacea.
- History of skin disorders, keloids (excessive scarring), abnormal wound healing, as well as very dry and fragile skin.
- History of bleeding disorders, or use of anticoagulants in the last 10 days.
- Any facial surgery performed within 12 months prior to treatment.
- Facial dermabrasion, facial resurfacing, or deep chemical peeling within the last 3 months.
- Received treatment with light, laser, radiofrequency (RF), or other devices in the treated area within 6 months.
- Used isotretinoin (Accutane®) within 6 months prior to treatment.
- Using of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) 1 week before and after each treatment session.
- Subjects that are currently or have recently been treated with Alpha-Hydroxi Acids (AHAs), Beta-Hydroxi Acids (BHAs), Retin-A®, topical retinoids or azelaic acid.
- Subjects that have been on a steroid regimen within the past 3 months.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678482
Canada, Ontario | |
SpaMedica | |
Toronto, Ontario, Canada, M5R3N8 |
Responsible Party: | Home Skinovations Ltd. |
ClinicalTrials.gov Identifier: | NCT01678482 |
Other Study ID Numbers: |
C1 |
First Posted: | September 5, 2012 Key Record Dates |
Last Update Posted: | September 5, 2012 |
Last Verified: | August 2012 |
Acne, LED, blue light |
Acne Vulgaris Acneiform Eruptions Skin Diseases Sebaceous Gland Diseases |